Mayo Clinic scientists believe they’ve found an enzyme that could defeat Alzheimer’s disease by destroying the brain-clogging protein that is a hallmark of the condition as it advances.Continue reading
Author Archive: AZBio
AZBio Announces Finalists for 2012 Bioscience Company of the Year
The 2012 Bioscience Company of the Year will be announced at the AZBio Awards on October 23, 2012 at the Phoenix Convention Center.Continue reading
UACC Study looks at Broccoli and Tamoxifen – Participants Needed
HealthTell Opens in Innovations Incubator
Chandler, AZ—HealthTell Inc., a new biotechnology start-up company, is expanding its operations to the Innovations Incubator in Chandler. HealthTell has developed a system for providing “immunosignatures” for early screening and diagnosis of multiple diseases such as cancer and Alzheimer’s.Continue reading
UA College of Medicine Researcher Gets $1.9 Million Federal Grant
Faculty Member Earns Prestigious Award for Schizophrenia ResearchContinue reading
NEA’s David Mott on what VC firm’s $2.6B fund means for biotech (biotechVC)
New Enterprise Associates packs financial firepower like few other venture capital outfits today, particularly those investing in biotech. Fresh off closing a diversified venture fund of $2.6 billion revealed in July, NEA is expected to spend roughly a third of its capital from the fund on healthcare investments primarily in the biopharma industry, General Partner David Mott (who sold MedImmune to AstraZeneca ($AZN) for $15.6 billion in 2007), told FierceBiotech.Continue reading
Brain State Technologies® Opens New Worldwide Brainwave Optimization™ Centers
With a global reach of 19 countries, partner network expands across U.S., Canada, Panama and Australia.Continue reading
Rick Myers To Receive the 2012 AZBio Public Service Award
A widely respected and tireless civic leader, Rick Myers is a visionary and a strong advocate for promoting the biosciences in Arizona. Rick serves as the Governor-appointed Chair for the Arizona Board of Regents and advocates for growing the research enterprise and promoting biosciences.Continue reading
Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
Revolutionary technique may enable new findings in what drives tumor cell growth and new targeted treatment options for patients1Continue reading
Living with an Artificial Heart
SynCardia Publishes 1st Brochure for Total Artificial Heart Patients & Their Caregivers
12-Page Resource Describes How the Total Artificial Heart Works, What to Expect Before & After Surgery and the Steps to Patient Discharge Using the Freedom® DriverContinue reading